CDKN2B-AS1 and cancer: Subsequently, data from different laboratories demonstrated that SNPs (single nucleotide polymorphisms) affecting the ANRIL gene are not only associated with cancer progression but also play a role in the development of metabolic disorders [179,180,181,182,183,184,185].